GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Amerisourcebergen Corporation (holding Co) (ABC) [hlAlert]

Rating:
Buy ABC
up 404.74 %

Amerisourcebergen Corporation (holding Co) (ABC) rated Buy with price target $73 by Argus

Posted on: Friday,  Nov 8, 2013  9:25 AM ET by Argus

Argus rated Buy Amerisourcebergen Corporation (holding Co) (NYSE: ABC) on 11/08/2013. Previously Argus rated Buy Amerisourcebergen Corporation (holding Co) (NYSE: ABC) on
08/04/2009., when the stock price was $20.04. Since then, Amerisourcebergen Corporation (holding Co) has gained 404.74% as of 11/18/2015's recent price of $101.15.
If you would have followed the previous Argus's recommendation on ABC, you would have gained 404.74% of your investment in 2297 days.

AmerisourceBergen Corporation (AmerisourceBergen) is a pharmaceutical services company, with operations in the United States and Canada. Servicing both healthcare providers and pharmaceutical manufacturers in the pharmaceutical supply channel, the Company provides drug distribution and related services. It distributes an offering of brand name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical and dialysis clinics, physicians, long-term care and other alternate site pharmacies, and other customers. The Company operates in the pharmaceutical distribution segment. In October 2008, the Company completed the divestiture of its former workers? compensation business, PMSI. On May 29, 2009, the Company acquired Innomar Strategies Inc.

Argus Research is an independent research firm, and our business is producing, distributing and marketing high-quality investment and economic research. Our recommendations - BUY, HOLD and SELL - reflect the judgment of an analyst about a company's prospects as an investment in terms of value, expected growth and risks. Argus Research does not bring companies public, advise companies on mergers and acquisitions, broker trades, make markets in stocks or manage money. Our independence allows us to make critical judgments about companies that we might not be so free to make were we competing for a firm's underwriting business. Because we're not a broker/dealer, we don't have "inventory" of a stock that we have to move with a tainted recommendation. We have developed a six-point system for analyzing the stocks in our Universe of Coverage. We believe that this system
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/13/2015 8:25 AM Buy
None
115.57 135.00
as of 12/13/2013
1 Week down  -2.61 %
1 Month down  -0.05 %
3 Months up  13.55 %
1 YTD up  58.52 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/24/2014 9:25 AM Buy
None
69.10 83.00
11/8/2013 9:25 AM Buy
None
68.00 73.00
3/20/2013 9:25 AM Buy
None
50.41 60.00
8/4/2009 8:25 AM Buy
None
20.04 25.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy